semaglutide newtown square Weight Loss Pottstown PA Weight Loss Program in Newtown

Cookies from third parties which may be used for personalization and determining your location

GLP-1 medications work by reducing appetite, improving metabolic function, and supporting sustainable weight loss

Two other clinical trials investigating subcutaneous liraglutide, 3.0 mg daily (ClinicalTrials.gov identifier NCT03712098), and subcutaneous dulaglutide, 1.5 mg once weekly (ClinicalTrials.gov identifier NCT03204396), are still recruiting

These are the highest results ever seen in anti-obesity medication to date

Sahni begins each weight loss journey with a thorough health assessment and a detailed discussion of your unique goals and lifestyle